Literature DB >> 10790886

Neurons and ECM regulate occludin localization in brain endothelial cells.

G Savettieri1, I Di Liegro, C Catania, L Licata, G L Pitarresi, S D'Agostino, G Schiera, V De Caro, G Giandalia, L I Giannola, A Cestelli.   

Abstract

We report that extracellular matrix and neurons modulate the expression of occludin, one of the main components of tight junctions, by rat brain endothelial cells (RBE4.B). Of the three extracellular matrix proteins which we tested (collagen I, collagen IV, and laminin), collagen IV stimulated at the best the expression of occludin mRNA. The corresponding protein, however, was not synthesized. Significant amounts of occludin accumulated only when RBE4.B cells were cultured on collagen IV-coated inserts, in the presence of cortical neurons, plated on laminin-coated companion wells. Finally, occludin segregated at the cell periphery, only when endothelial cells were co-cultured with neurons for > or = 1 week.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790886     DOI: 10.1097/00001756-200004070-00035

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  31 in total

Review 1.  Targeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Ther Deliv       Date:  2011-08

2.  Adult human dental pulp stem cells promote blood-brain barrier permeability through vascular endothelial growth factor-a expression.

Authors:  Joshua N Winderlich; Karlea L Kremer; Simon A Koblar
Journal:  J Cereb Blood Flow Metab       Date:  2015-10-02       Impact factor: 6.200

3.  Differentiating embryonic neural progenitor cells induce blood-brain barrier properties.

Authors:  Christian Weidenfeller; Clive N Svendsen; Eric V Shusta
Journal:  J Neurochem       Date:  2007-01-24       Impact factor: 5.372

Review 4.  Blood-brain barrier: structural components and function under physiologic and pathologic conditions.

Authors:  Yuri Persidsky; Servio H Ramirez; James Haorah; Georgette D Kanmogne
Journal:  J Neuroimmune Pharmacol       Date:  2006-07-06       Impact factor: 4.147

5.  Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds.

Authors:  John P Frampton; Michael L Shuler; William Shain; Matthew R Hynd
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2008

Review 6.  Blood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in stroke.

Authors:  Patrick T Ronaldson; Thomas P Davis
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

7.  Blood-brain barrier modeling with co-cultured neural progenitor cell-derived astrocytes and neurons.

Authors:  Ethan S Lippmann; Christian Weidenfeller; Clive N Svendsen; Eric V Shusta
Journal:  J Neurochem       Date:  2011-09-21       Impact factor: 5.372

8.  Modeling the blood-brain barrier: Beyond the endothelial cells.

Authors:  Benjamin D Gastfriend; Sean P Palecek; Eric V Shusta
Journal:  Curr Opin Biomed Eng       Date:  2018-03

Review 9.  Cell-culture models of the blood-brain barrier.

Authors:  Yarong He; Yao Yao; Stella E Tsirka; Yu Cao
Journal:  Stroke       Date:  2014-06-17       Impact factor: 7.914

10.  An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.

Authors:  Scott G Canfield; Matthew J Stebbins; Bethsymarie Soto Morales; Shusaku W Asai; Gad D Vatine; Clive N Svendsen; Sean P Palecek; Eric V Shusta
Journal:  J Neurochem       Date:  2017-02-14       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.